DR. JEFFREY MARK SMITH, M.D.
Medical Practice at Convoy St, San Diego, CA
License number
California G83625
Category
Medical Practice
Type
Orthopaedic Surgery
Address
Address
3750 Convoy St SUITE 201, San Diego, CA 92111
Phone
(858) 278-8031
(858) 278-1708 (Fax)
(858) 278-1708 (Fax)
Personal information
See more information about JEFFREY MARK SMITH at radaris.comName
Address
Phone
4730 Pheasant Dr, Anderson, CA 96007
4716 E Bradford Ave, Orange, CA 92867
4711 Hillard Ave, La Canada Flintridge, CA 91011
4752 Gabriel Way, La Mesa, CA 91941
4807 Browndeer Ln, Rch Palos Vrd, CA 90275
Professional information
Professor At Burnham Institute For Medical Reserch
Position:
Professor at BIMR, Professor at The Burnham Institute
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
BIMR
-
Professor
The Burnham Institute
since 1994
-
Professor
Prize Capital
2004 - 2005
-
none
ActivX Biosciences
2000 - 2003
-
Founder
Education:
University of California, Irvine 1983 - 1987
Ph.D>, Cell Biology University of California, Santa Barbara 1979 - 1983
B.A., Biology
Ph.D>, Cell Biology University of California, Santa Barbara 1979 - 1983
B.A., Biology
Owner, Got Uke?
Position:
Owner at got uke?
Location:
Greater San Diego Area
Industry:
Music
Work:
got uke?
-
Owner
Education:
San Diego State University-California State University 1977 - 1983
MB High
MB High
Test Engineer At Hunter Industries
Position:
Test Engineer at Hunter Industries
Location:
Greater San Diego Area
Industry:
Plastics
Work:
Hunter Industries
-
Test Engineer
Owner, Country Appraisal Service
Position:
Owner at COUNTRY APPRAISAL SERVICE
Location:
Greater San Diego Area
Industry:
Real Estate
Work:
COUNTRY APPRAISAL SERVICE
-
Owner
Realtor/Advisor At Real Estate/Mortgage/Financial Advisor
Position:
realtor/advisor at real estate/mortgage/financial advisor
Location:
Greater San Diego Area
Industry:
Financial Services
Work:
real estate/mortgage/financial advisor
-
realtor/advisor
Independent Financial Services Professional
Location:
Greater San Diego Area
Industry:
Financial Services
Student At San Diego State University-California State University
Location:
Greater San Diego Area
Industry:
E-Learning
Education:
San Diego State University-California State University 2003 - 2007
Serine/Threonine Hydrolase Proteins And Screening Assays
US Patent:
2006017, Aug 3, 2006
Filed:
Jan 30, 2006
Appl. No.:
11/343911
Inventors:
Jeffrey Smith - San Diego CA, US
Steven Kridel - San Diego CA, US
Fumiko Axelrod - San Diego CA, US
Steven Kridel - San Diego CA, US
Fumiko Axelrod - San Diego CA, US
International Classification:
A61K 39/395, C07H 21/04, C12P 21/06, C12N 9/64
US Classification:
424145100, 424178100, 435226000, 435069100, 435320100, 435325000, 530388260, 536023200
Abstract:
Proteins specific for prostate epithelial cells, normal or neoplastic, are identified and used for diagnosis, development of antibodies, and for evaluating drugs that react with the neoplastic specific proteins. Affinity based probes are used that react specifically with the active site to provide a measure of the enzyme activity of the cells. Prostate epithelial neoplastic cells can be used in screening candidate drugs for their effect in changing the proteome profile as to the serine-threonine hydrolase enzymes, using the affinity based probes for determining the profile.
Integrin Ligand Dissociators
US Patent:
6184206, Feb 6, 2001
Filed:
Sep 2, 1998
Appl. No.:
9/146503
Inventors:
Jeffrey W. Smith - San Diego CA
Dana D. Hu - Maryland Heights MO
Dana D. Hu - Maryland Heights MO
Assignee:
The Burnham Institute - La Jolla CA
International Classification:
A61K 3800, A61K 3514, C07K 500
US Classification:
514 14
Abstract:
The invention provides a method of disaggregating a ligand:integrin receptor complex. Specifically, the invention provides a method of disaggregating an existing platelet thrombus in a blood vessel in a subject, comprising administering to the subject a compound which dissociates fibrinogen bound to a first site on platelet glycoprotein IIB-IIIa, by binding a second interacting site on the platelet glycoprotein IIB-IIIa, thereby disaggregating the platelet thrombus. The present invention also provides a method of screening compounds for the ability to dissociate a ligand from its integrin receptor by binding an interacting second site, comprising contacting the compound with an existing ligand:integrin receptor complex and determining if the complex dissociates.
5Ht2C Receptor Modulators
US Patent:
8207158, Jun 26, 2012
Filed:
May 27, 2011
Appl. No.:
13/118126
Inventors:
Brian Smith - San Diego CA, US
Jeffrey Smith - San Diego CA, US
Jeffrey Smith - San Diego CA, US
Assignee:
Arena Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61P 25/18, A61P 25/22, A61P 25/24, A61P 43/00
US Classification:
51421202, 514215, 51421701
Abstract:
The present invention relates to novel compounds of Formula (I):.